Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTC:INLB NASDAQ:IONM OTCMKTS:LENSF OTCMKTS:TOMDF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINLBItem 9 Labs$0.00$0.00▼$0.10$70K0.7713.46 million shsN/AIONMAssure$0.05$0.04$0.03▼$0.55$150K185.755,156 shs1 shsLENSFPresbia$0.02$0.02$0.00▼$0.19$257K5.915,650 shsN/ATOMDFTodos Med$0.00$0.00▼$0.00N/A-0.0148,274 shsN/A7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINLBItem 9 Labs0.00%0.00%0.00%0.00%0.00%IONMAssure0.00%0.00%+65.52%+47,900.00%-90.40%LENSFPresbia0.00%0.00%0.00%0.00%0.00%TOMDFTodos Med0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINLBItem 9 LabsN/AN/AN/AN/AN/AN/AN/AN/AIONMAssureN/AN/AN/AN/AN/AN/AN/AN/ALENSFPresbiaN/AN/AN/AN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINLBItem 9 Labs 0.00N/AN/AN/AIONMAssure 0.00N/AN/AN/ALENSFPresbia 0.00N/AN/AN/ATOMDFTodos Med 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINLBItem 9 Labs$21.76M0.00N/AN/AN/ANaNIONMAssure$149K1.01N/AN/A($41.04) per share0.00LENSFPresbiaN/AN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINLBItem 9 Labs-$31.14MN/A0.00N/AN/AN/AN/AN/AN/AIONMAssure-$26.08MN/A0.00∞N/A-25,178.32%N/A-249.78%N/ALENSFPresbiaN/AN/A0.00∞N/AN/AN/AN/AN/ATOMDFTodos MedN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINLBItem 9 LabsN/AN/AN/AN/AN/AIONMAssureN/AN/AN/AN/AN/ALENSFPresbiaN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINLBItem 9 LabsN/AN/AN/AIONMAssureN/A0.200.20LENSFPresbiaN/AN/AN/ATOMDFTodos MedN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINLBItem 9 LabsN/AIONMAssure3.33%LENSFPresbiaN/ATOMDFTodos MedN/AInsider OwnershipCompanyInsider OwnershipINLBItem 9 Labs19.80%IONMAssure3.80%LENSFPresbia74.20%TOMDFTodos MedN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINLBItem 9 Labs100701.92 million562.85 millionNot OptionableIONMAssure1303.13 million3.02 millionNot OptionableLENSFPresbia2017.12 millionN/ANot OptionableTOMDFTodos Med7N/AN/ANot OptionableINLB, LENSF, TOMDF, and IONM HeadlinesRecent News About These CompaniesTodos os Golos do Dia na UEFA Champions LeagueOctober 25, 2024 | pt.uefa.comPVamos Todos MorrerSeptember 6, 2024 | rtp.ptRTodos Medical Ltd TOMDFApril 5, 2024 | morningstar.comMTodos Medical Ltd.: Todos Medical Announces Insolvency Proceedings in IsraelDecember 23, 2023 | finanznachrichten.deTodos Medical Announces Insolvency Proceedings in IsraelDecember 22, 2023 | finance.yahoo.comTOMDF Historical DataOctober 2, 2023 | investing.comTodos Medical Provides Corporate Update: Retooling to Focus on Long COVID EpidemicSeptember 26, 2023 | finance.yahoo.comTodos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ IngredientsAugust 30, 2023 | finance.yahoo.comTodos Medical Ltd. (TOMDF)May 24, 2023 | finance.yahoo.comTodos Medical's Letter of Intent with Provista Diagnostics set to license sepsis diagnostic testingMarch 31, 2023 | finance.yahoo.comTodos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic testMarch 28, 2023 | proactiveinvestors.comTodos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen DiagnosticsMarch 28, 2023 | finance.yahoo.comTodos Medical Begins Trading on the OTC Pink MarketplaceMarch 27, 2023 | finance.yahoo.comTodos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patientsMarch 17, 2023 | proactiveinvestors.comTodos Medical Supports Long COVID Awareness DayMarch 15, 2023 | finance.yahoo.comTodos Medical Enters Into Moratorium on ConversionsMarch 13, 2023 | vietreader.comVTodos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note HoldersMarch 13, 2023 | finance.yahoo.comTodos Medical releases corporate update around validation plan for PCR-based Avian Influenza testingFebruary 24, 2023 | proactiveinvestors.comTodos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rolloutFebruary 23, 2023 | proactiveinvestors.comTodos Medical says Provista Diagnostics lab kicks off validation plan for PCR-based bird flu test for humansFebruary 14, 2023 | proactiveinvestors.comINLB, LENSF, TOMDF, and IONM Company DescriptionsItem 9 Labs OTC:INLBItem 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.Assure NASDAQ:IONM$0.05 0.00 (0.00%) As of 08/11/2025Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.Presbia OTCMKTS:LENSF$0.02 0.00 (0.00%) As of 10/21/2022Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.Todos Med OTCMKTS:TOMDFTodos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intel's White House Reset: From Political Storm to a Clearer Sky AST SpaceMobile on Track for Explosive Upside Oklo’s Stock Is Set up for a Correction—Buy It When It Bounces If Qualcomm Holds $145, Its Next Move Could Be Massive Alphabet Reclaims $200 Threshold—Bull Run Reignited? NFL and WWE Land on ESPN—The Impact on Disney and TKO Stocks Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside Apple & Trump: $100B Investment, Tariffs News Push Shares Up 13% Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access